Our Mission
GYNOCARE aims to create a unique network between key stakeholders covering five distinct domains (from concept to cure): basic research on rare gynaecological cancer, biobanking, industrial dimension, legal and regulatory requirements for international trials and other research collaborative efforts, and high-quality, international, and innovative clinical trials. To achieve our ambitious goals, we have devised research coordination and capacity building objectives in accordance with mission and vision of the COST Action.
GYNOCARE will focus on (1) capacity-building on rare gynaecological cancer by connecting high-quality scientific communities in various disciplines, existing networks, policy-makers, industrial partners, and patient organisations across Europe and beyond; (2) coordinating, and contributing to the development of a research roadmap dedicated to connect innovative basic research to harmonised biobanking to ‘smarter’ clinical trials; (3) developing a platform for sharing best practices, including funding roadmap and legal/ethical requirements, in gynaecological cancers, aiming to advice policy-makers and other key stakeholders; and (4) providing equal networking opportunities for early-stage researchers, and other talented young professionals.
GYNOCARE will focus on (1) capacity-building on rare gynaecological cancer by connecting high-quality scientific communities in various disciplines, existing networks, policy-makers, industrial partners, and patient organisations across Europe and beyond; (2) coordinating, and contributing to the development of a research roadmap dedicated to connect innovative basic research to harmonised biobanking to ‘smarter’ clinical trials; (3) developing a platform for sharing best practices, including funding roadmap and legal/ethical requirements, in gynaecological cancers, aiming to advice policy-makers and other key stakeholders; and (4) providing equal networking opportunities for early-stage researchers, and other talented young professionals.
Main Contacts
Prof Jean Calleja-Agius
Dr Vera Dimitrievska
Prof David Faraggi
Dr Maria Santos
Dr Federica Ortelli
Dr Riccardo Di Fiore
Ms Aldona Gembalik
Ms Diandra Borg-Meli
Latest News
0.0
million gynae cancer patients
0%
rare gynae cancers
0
countries
0+
professionals
Latest Events
Kick-off Meeting under newly appointed Action Chairperson
Online meeting held on the 26th October 2020 10:00-12:00hrs
Our Work
Patients
Open invitation to representatives of patient support groups
Clinical Trials
Opportunities for collaboration in innovative multicentre clinical trials
Treatment
Transfer of novel technologies to enhance personalised precision medicine